At CPHI Milan 2026, Ruby Collier of ARTO sat down with Jamie Beaumont and Catherine Parry of COREX for an episode of Making It In Manufacturing.

They talked about where a specialist supply partner fits in the clinical supply chain, why the comparator needs as much planning as the investigational product, and what sponsors should consider before starting a global trial.



Speak to your supply partner before the decisions are made

Ruby asked when sponsors usually realise they have a supply problem. Jamie’s answer was direct: probably too late. “Please speak to us,” he says, urging sponsors to involve their supply partner before they make key decisions.

The earlier the conversation, the more options remain open. This matters most when a programme moves from pre-clinical into clinical, when the study team is new and the timelines are tight.

Plan the comparator with the IMP

Sponsors often plan the investigational medicinal product (IMP) months ahead, while the comparator gets far less attention. Jamie’s advice is to plan both together. A comparator is a licensed medicine bought on the market, so its availability depends on shortages, pack sizes, expiry dates and the documents the sponsor’s Qualified Person needs.

What sponsors should expect from a supply partner

Ruby also asked what sets a specialist supply partner apart from the large logistics and CDMO players. Jamie points to four things: “reliability, supply chain security, knowledge, and the personal touch”.

Some COREX clients have worked with the company since the very beginning and recommend it to their peers. In Jamie’s words, the culture inside shows on the outside.

Advice for sponsors planning a global trial

Asked what he would tell a sponsor starting a global trial tomorrow, Jamie stresses the importance of giving the team enough time to plan. Assess the logistical challenges and regulatory requirements in each trial country early. Then choose supply routes that can reliably get medicines to patients throughout the study.

Three signals that a supply plan is late

From our project team, three early warnings to look for in your own study:
  1. The site activation date moves forward, but the import permit application has not started.
  2. The comparator quantity is agreed, but nobody has checked which pack sizes are available.
  3. The label text is still in review two weeks before the first shipment.

Each is easy to fix early. If you see one, give it an owner and a date.

About the speakers

Jamie Beaumont is Global Head of Clinical Trial Sourcing at COREX. He works with sponsors on comparator sourcing and supply planning for clinical trials.

Catherine Parry is Business Development Director – CTS at COREX, with a focus on comparator and ancillary sourcing and global distribution.

About the conversation

This episode was recorded at CPHI Milan 2026 for Making It In Manufacturing by ARTO. Our thanks to Ruby Collier and the ARTO team.

COREX has supported clinical trials and access to medicines for 15 years. Its global network covers 45+ countries, and its services include comparator sourcing, clinical trial logistics and storage.

Planning your first-patient date? Fill in the form below to discuss comparator sourcing with our team.

Back to the list